top of page

Reviews, Guidelines, etc.

  1. Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A; Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics. Statin Intolerance Clinical Guide 2018. J Atheroscler Thromb. 2020 Apr 1;27(4):375-396. doi: 10.5551/jat.50948. PMID: 31588101; PMCID: PMC7192817.

  2. Kagawa T. Hepatobiliary transport of bile acids. In “Bile Acids in Gastroenterology: Basic and Clinical (edited by Susumu Tazuma and Hajime Takikawa)”, 2017, pp. 9-25.

  3. Kagawa T, Keeffe EB. Long-term effects of antiviral therapy in patients with chronic hepatitis C. Hepat Res Treat. 2010;2010:562578. doi: 10.1155/2010/562578. PMID: 21188198; PMCID: PMC3003987.

  4. Kagawa T, Keeffe EB, Yu ML. Pegylated interferon and ribavirin treatment for hepatitis C virus infection. Hepat Res Treat. 2010;2010:275274. doi:10.1155/2010/275274. PMID: 21253448; PMCID: PMC3023034

bottom of page